SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-060283
Filing Date
2019-11-06
Accepted
2019-11-06 08:31:46
Documents
83
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm1919471-1_10q.htm 10-Q 988319
2 EXHIBIT 31.1 tm19194711_ex31-1.htm EX-31.1 10094
3 EXHIBIT 31.2 tm19194711_ex31-2.htm EX-31.2 11632
4 EXHIBIT 32.1 tm19194711_ex32-1.htm EX-32.1 5555
  Complete submission text file 0001104659-19-060283.txt   8201396

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT anip-20190930.xml EX-101.INS 2364865
6 XBRL TAXONOMY EXTENSION SCHEMA anip-20190930.xsd EX-101.SCH 60085
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE anip-20190930_cal.xml EX-101.CAL 71425
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE anip-20190930_def.xml EX-101.DEF 237494
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20190930_lab.xml EX-101.LAB 425571
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20190930_pre.xml EX-101.PRE 428023
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 191195170
SIC: 2834 Pharmaceutical Preparations